Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Honoré, Patrick M ^a   Jacobs, Rita ^a   De Regt, Jouke ^a   Van Gorp, Viola ^a   De Waele, Elisabeth ^a   Spapen, Herbert D ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; COLISTIN; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DIALYSIS MEMBRANE; HUMAN; KIDNEY TUBULE ABSORPTION; LETTER; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MULTIDRUG RESISTANT PSEUDOMONAS INFECTION; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; CRITICAL ILLNESS; DOSE RESPONSE; DRUG EFFECTS; MULTIDRUG RESISTANCE; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; COLISTIN; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; HUMANS; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

EID: 84896888219     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13747     Document Type: Letter

References (5)

1. Rocco M, Montini L, Alessandri E, Venditti M, Laderchi A, De Pascale G, Raponi G, Vitale M, Pietropaoli P, Antonelli M. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study. Crit Care 2013, 17:R174. 10.1186/cc12853, 23945197.
2. Rashid S, Saro-Nunez L, Kumar A, Patel A, Parikh A. Acute kidney injury: taking aim at colistin. Crit Care 2014, 18:401. 10.1186/cc13703, 24447506.
3. Mohamed AF, Karaiskos I, Plachouras D, Karvanen M, Pontikis K, Jansson B, Papadomichelakis E, Antoniadou A, Giamarellou H, Armaganidis A, Cars O, Friberg LE. Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother 2012, 56:4241-4249. 10.1128/AAC.06426-11, 3421626, 22615285.
4. Honore PM, Jacobs R, Joannes-Boyau O, Boer W, De Waele E, Van Gorp V, Spapen HD. Continuous renal replacement therapy allows higher colistin dosing without increasing toxicity. J Transl Intern Med 2013, 1:6-8.
5. Honore PM, Jacobs R, Lochy S, De Waele E, Van Gorp V, De Regt J, Martens G, Joannes-Boyau O, Boer W, Spapen HD. Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration. Int J Nephrol Renovasc Dis 2013, 6:107-111. 3681400, 23776390.